|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 283, Issue 36, 24506-24513, September 5, 2008
Supramolecular Interactions in the Dermo-epidermal Junction ZoneANCHORING FIBRIL-COLLAGEN VII TIGHTLY BINDS TO BANDED COLLAGEN FIBRILS*![]() ![]() 1 2 23
From the
The dermis and the epidermis of normal human skin are functionally separated by a basement membrane but, together, form a stable structural continuum. Anchoring fibrils reinforce this connection by insertion into the basement membrane and by intercalation with banded collagen fibrils of the papillary dermis. Structural abnormalities in collagen VII, the major molecular constituent of anchoring fibrils, lead to a congenital skin fragility condition, dystrophic epidermolysis bullosa, associated with skin blistering. Here, we characterized the molecular basis of the interactions between anchoring fibrils and banded collagen fibrils. Suprastructural fragments of the dermo-epidermal junction zone were generated by mechanical disruption and by separation with magnetic Immunobeads. Anchoring fibrils were tightly attached to banded collagen fibrils. In vitro binding studies demonstrated that a von Willebrand factor A-like motif in collagen VII was essential for binding of anchoring fibrils to reconstituted collagen I fibrils. Since collagen I and VII molecules reportedly undergo only weak interactions, the attachment of anchoring fibrils to collagen fibrils depends on supramolecular organization of their constituents. This complex is stabilized in situ and resists dissociation by strong denaturants.
Received for publication, March 27, 2008 , and in revised form, July 1, 2008. * This work was supported by the Deutsche Forschungsgemeinschaft SFB 492 Grants A2 (to P. B.), KO 2247/3-1 (to M. K.), and Br 1475/8-2 (to L. B.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Supported by the German Ministry of Education and Science, Kompetenznetz "Epidermolysis Bullosa." 2 Both authors contributed equally to this work. 3 To whom correspondence should be addressed: Münster University Hospital, Physiological Chemistry and Pathobiochemistry, Waldeyerstrasse 15, 48149 Münster, Germany. Tel.: 49-251-8355591; Fax: 49-251-8355596; E-mail: peter.bruckner{at}uni-muenster.de.
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||